Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00469742 · ClinicalTrials.gov registry record
Aprotinin in Neonates Undergoing Cardiopulmonary Bypass
A clinical trial of Cardiopulmonary Bypass and Hemostasis, sponsored by Children's Healthcare of Atlanta.
- Completed
- Registry status
- 290
- Enrollment target
- 1
- Study location
NCT00469742: Completed study of Cardiopulmonary Bypass and Hemostasis, sponsored by Children's Healthcare of Atlanta.
NCT00469742 is a study of Cardiopulmonary Bypass and Hemostasis that has completed, run by Children's Healthcare of Atlanta. The registered enrollment target is 290 participants, below the 671-participant average among 10 other Cardiopulmonary Bypass trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00469742, a study of Cardiopulmonary Bypass and Hemostasis, has completed, sponsored by Children's Healthcare of Atlanta.
- COMPLETED
- Registry status
- 290 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a retrospective chart review study. The purpose of this study is to review our experience at Children's Healthcare of Atlanta in neonates receiving aprotinin. We will examine the specific outcomes of renal dysfunction, thrombosis and mortality.
Conditions Studied
Study Locations (1)
Georgia
- Children's Healthcare of Atlanta - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2007-04 |
| Est. Completion | 2008-12 |
What the finished NCT00469742 record still lists
NCT00469742 is an observational study that tracks outcomes without assigning an intervention. The registered 290 participants enrollment target is mid-sized for trials with a published cap, below the 671-participant average among 10 other Cardiopulmonary Bypass trials with a reported enrollment target (57% lower).
The record links to 3 conditions, with Cardiopulmonary Bypass appearing as the primary indexed condition, and to 0 interventions.
NCT00469742 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT00469742 about?
NCT00469742 is a clinical study titled "Aprotinin in Neonates Undergoing Cardiopulmonary Bypass". This is a retrospective chart review study. The purpose of this study is to review our experience at Children's Healthcare of Atlanta in neonates receiving aprotinin. We will examine the specific outcomes of renal dysfunction, thrombosis and mortality.
What is the current status of trial NCT00469742?
This trial is currently completed. The enrollment target is 290 participants. The study started on 2007-04. Estimated completion is 2008-12.
What conditions does trial NCT00469742 study?
This clinical trial studies the following conditions: Cardiopulmonary Bypass, Hemostasis, Congenital Defects.
Who is sponsoring clinical trial NCT00469742?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00469742 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiopulmonary Bypass
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00469742's enrollment target sits among peer trials
290 7th of 10 higher than 4 of 10 other Cardiopulmonary Bypass trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiopulmonary Bypass trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neutrophil Phenotypic Profiling and Acute Lung Injury in Patients After Cardiopulmonary Bypass (CPB)
RECRUITING
-
Cardiopulmonary Bypass Induced Red Blood Cell Lysis
RECRUITING
-
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
RECRUITING · Phase 3
-
ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE
ACTIVE NOT RECRUITING · Phase 3
-
Impact of Pulsatile Cardio-Pulmonary Bypass (CPB) on Vital Organ Recovery
ACTIVE NOT RECRUITING
-
SPY Imaging System: Its Role in Pediatric Cardiac Surgery
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
- NCT04649008 · 290 participants · Early Phase 1
Localizing Epileptic Networks Using MRI and iEEG
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia